This article has been cited by other articles in PMC.
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (521K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
These references are in PubMed. This may not be the complete list of references from this article.
Binedell J, Soldan JR, Scourfield J, Harper PS. Huntington's disease predictive testing: the case for an assessment approach to requests from adolescents. J Med Genet. 1996 Nov;33(11):912–918.[PMC free article][PubMed]
Kessler S. Invited essay on the psychological aspects of genetic counseling. V. Preselection: a family coping strategy in Huntington disease. Am J Med Genet. 1988 Nov;31(3):617–621.[PubMed]
Marteau TM, van Duijn M, Ellis I. Effects of genetic screening on perceptions of health: a pilot study. J Med Genet. 1992 Jan;29(1):24–26.[PMC free article][PubMed]
Goodall J. Helping a child to understand her own testicular feminisation. Lancet. 1991 Jan 5;337(8732):33–35.[PubMed]
Wray R, Neil H, Rees J. Screening for hyperlipidaemia in childhood. Recommendations of the British Hyperlipidaemia Association. J R Coll Physicians Lond. 1996 Mar-Apr;30(2):115–118.[PubMed]
Geva T, Hegesh J, Frand M. The clinical course and echocardiographic features of Marfan's syndrome in childhood. Am J Dis Child. 1987 Nov;141(11):1179–1182.[PubMed]
Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med. 1994 May 12;330(19):1335–1341.[PubMed]
Ravine D, Walker RG, Gibson RN, Sheffield LJ, Kincaid-Smith P, Danks DM. Treatable complications in undiagnosed cases of autosomal dominant polycystic kidney disease. Lancet. 1991 Jan 19;337(8734):127–129.[PubMed]
Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Strachan T, Harris R. A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. J Med Genet. 1992 Dec;29(12):847–852.[PMC free article][PubMed]
Maddock IR, Moran A, Maher ER, Teare MD, Norman A, Payne SJ, Whitehouse R, Dodd C, Lavin M, Hartley N, et al. A genetic register for von Hippel-Lindau disease. J Med Genet. 1996 Feb;33(2):120–127.[PMC free article][PubMed]
Wertz DC, Fanos JH, Reilly PR. Genetic testing for children and adolescents. Who decides? JAMA. 1994 Sep 21;272(11):875–881.[PubMed]
Goodwin JF. Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. Hypertrophic cardiomyopathy can be treated but not cured. BMJ. 1995 Jul 1;311(6996):58–58.[PMC free article][PubMed]
Marteau T, Michie S. Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. A positive screening test for an untreatable condition provides psychological relief from uncertainty. BMJ. 1995 Jul 1;311(6996):58–59.[PMC free article][PubMed]
Dalby S. GIG response to the UK Clinical Genetics Society report "The genetic testing of children". J Med Genet. 1995 Jun;32(6):490–491.[PMC free article][PubMed]
Balfour-Lynn I, Madge S, Dinwiddie R. Testing carrier status in siblings of patients with cystic fibrosis. Arch Dis Child. 1995 Feb;72(2):167–168.[PMC free article][PubMed]
Laird L, Dezateux C, Anionwu EN. Neonatal screening for sickle cell disorders: what about the carrier infants? BMJ. 1996 Aug 17;313(7054):407–411.[PMC free article][PubMed]